Cofactor Genomics is using machine learning and RNA sequencing to build multidimensional biomarkers that can accurately stratify patients as responders or non-responders to different therapies. Bridging this gap in immune-oncology alone would save US healthcare billions in annual costs and deliver on this promise of more precise healthcare for patients.
Presented by Natalie LaFranzo, VP Market Development / Cofactor Genomics